Canopy Growth received EU GMP certification from RP Tuebingen, Regional Health Inspectorate of Baden-Wuerttemberg, for the Company’s world-class cannabis cultivation facility in Kincardine, Ontario.

As a final step to completing the Company’s consolidation of its production footprint into two purpose-built sites, the receipt of EU GMP certification enables Canopy Growth to continue exporting certified medical cannabis to medical markets in Europe as well as other medical cannabis markets around the world.

“The receipt of EU GMP certification for our Kincardine facility is a significant milestone for Canopy Growth as we complete the transformation of our business and position it for long-term growth and market leadership,” said David Klein, Chief Executive Officer of Canopy Growth. “Today’s announcement further demonstrates our team’s proven ability to evolve our business and positions us to continue serving medical cannabis customers in Europe and around the world with high-quality flower.”

For more information:
Canopy Growth